Beauty Farm Medical and Health Industry (2373) Fundamentals 2026 — P/E 12.1x, Revenue Analysis | SniperIQ

9.41 on the HKSE. This SniperIQ fundamentals page covers Beauty Farm Medical and Health Industry's valuation (P/E 12.1x, P/B 3.8x), profitability (net margin 10.6%), revenue (¥3.0B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Full research coverage

• 8-Quarter Revenue & Margin Trend
• Debt Maturity & Coverage
• Peer Valuation Comparison
• Free Cash Flow & Owner Earnings
• AI Signal + Institutional Flow
• DCF Valuation Model

Frequently Asked Questions

What is Beauty Farm Medical and Health Industry's market cap?

Beauty Farm Medical and Health Industry (2373) has a market capitalization of approximately HK$4.8B, trading at HK

9.41 on the HKSE. Market cap moves with the live share price.

What is Beauty Farm Medical and Health Industry's P/E ratio?

Beauty Farm Medical and Health Industry's trailing twelve-month P/E ratio is 12.1x, with a price-to-book (P/B) of 3.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Beauty Farm Medical and Health Industry?

Beauty Farm Medical and Health Industry runs a net profit margin of 10.6%, a gross margin of 49.1%, and an operating margin of 15.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Beauty Farm Medical and Health Industry generate?

Beauty Farm Medical and Health Industry reported revenue of ¥3.0B for fiscal year 2025, with net income of ¥318M and earnings per share (EPS) of 1.38. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Beauty Farm Medical and Health Industry pay a dividend?

Beauty Farm Medical and Health Industry offers a trailing dividend yield of about 2.7%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Beauty Farm Medical and Health Industry financially healthy?

Beauty Farm Medical and Health Industry carries a debt-to-equity ratio of 1.27x and a current ratio of 0.98x, with a market beta of 1.35. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Beauty Farm Medical and Health Industry a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Beauty Farm Medical and Health Industry (2373) the key facts are: market cap HK$4.8B, P/E 12.1x, revenue ¥3.0B, 52-week range 15.6-41.6. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.